Literature DB >> 9802535

Chronic and acute prenatal and postnatal ethanol exposure on lymphocyte subsets from offspring thymic, splenic, and intestinal intraepithelial sources.

K B Basham1, S P Whitmore, A F Adcock, P V Basta.   

Abstract

The overall objective of this study was to analyze the effects of a combined prenatal and postnatal (entire gestational human chronic drinking model) ethanol exposure on T-cell development in mice. Specifically, this study evaluated the effects of chronic exposure to prenatal ethanol on lymphocyte makeup and proliferative capabilities of postnatal offspring's (4 and 12 weeks) peripheral lymphoid tissues. Chronic exposure regimens were conducted over the entire gestational period and through postnatal day 14 or 21. Thymus, spleen, and intestinal intraepithelial lymphocytes were harvested and analyzed by flow cytometry for percentages of T-cell subsets. Splenic lymphocytes were also analyzed for their ability to proliferate in response to a T-cell mitogen. Limited effects of chronic ethanol exposure were seen.

Entities:  

Mesh:

Year:  1998        PMID: 9802535

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  3 in total

1.  Prenatal alcohol exposure potentiates chronic neuropathic pain, spinal glial and immune cell activation and alters sciatic nerve and DRG cytokine levels.

Authors:  Shahani Noor; Joshua J Sanchez; Arden G Vanderwall; Melody S Sun; Jessie R Maxwell; Suzy Davies; Lauren L Jantzie; Timothy R Petersen; Daniel D Savage; Erin D Milligan
Journal:  Brain Behav Immun       Date:  2016-12-20       Impact factor: 7.217

2.  Fetal exposure to ethanol has long-term effects on the severity of influenza virus infections.

Authors:  Jodi McGill; David K Meyerholz; Michelle Edsen-Moore; Betty Young; Ruth A Coleman; Annette J Schlueter; Thomas J Waldschmidt; Robert T Cook; Kevin L Legge
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

3.  Prenatal alcohol exposure is a risk factor for adult neuropathic pain via aberrant neuroimmune function.

Authors:  Joshua J Sanchez; Shahani Noor; Suzy Davies; Daniel Savage; Erin D Milligan
Journal:  J Neuroinflammation       Date:  2017-12-19       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.